When ‘Medical’ Looks Like Marketing: A Quiet Threat to Patient Care

The hidden danger to medical treatment becomes apparent when medical language resembles commercial advertising.

Having spent twenty seven years in sales & marketing roles I understand the strength of brand development. Properly implemented brand communication develops narratives which draw in audiences while creating enduring customer devotion. The medical cannabis industry requires precise boundary maintenance between compelling narratives and marketing excess, because this boundary affects the delivery of patient care.

The UK medical cannabis industry has made me more aware than ever of how brand presentation affects trust building while simultaneously destroying it. The blurring between medical content and marketing practices threatens to destroy both professional credibility and patient medical care.

Medical cannabis remains in its early stages of development, even though we are edging near seven years of medical legality, throughout the United Kingdom. This sector exists within a complex regulatory framework since it operates under medical supervision (MHRA etc), yet faces public confusion and governmental caution. Every visual element and product name and marketing tagline holds crucial importance for the medical cannabis industry.

The legacy cannabis industry draws natural interest through its essential branding strategies, cultural signals and strain (cultivar) popularity. Medical professionals require the medical field to emphasise consistency alongside traceability and scientific evidence in their practices. Legitimate operators face the risk of undermining their hard-won progress when medical and consumer branding elements become mixed accidentally.

Patients require to have faith in their prescribed medication. The medical community demands assurance when they consider making pharmaceutical prescriptions. Public health-oriented regulation requires the industry to demonstrate its status as a healthcare-focused operation instead of a marketing-driven enterprise. Our brand appearance should avoid recreational characteristics because such presentation creates confusion about medical treatment versus temporary trends.

It’s not about being bland. It’s about being responsible. While strain names alone do not influence patients to switch medications, it is essential that product packaging and visual branding clearly distinguish medical cannabis from recreational use; ensuring its purpose is easily understood across clinical and public settings.

Many of us are personally invested in this space; we’ve seen cannabis change lives, and we care deeply. But personal passion is not the same as public messaging. At Dalgety, our focus is medicine. From cultivation to communication, everything we do is guided by clinical standards, not recreational appeal. We prioritise evidence, accuracy, and transparency over attention; because patients deserve nothing less.

Marketing initiatives within this field need to draw patients through informative and trustworthy content. The goal of good marketing in this sector involves teaching patients & medical practitioners, while providing them with assurance about medical cannabis as an official regulated therapeutic choice.

The area of fading stigma combined with remaining confusion makes people seek guidance from trusted authorities. Influencers together with patient advocates and online communities maintain significant power in shaping how others perceive things. The influence one possesses requires them to take responsibility.

There’s a growing community of voices online sharing experiences and information about medical cannabis; many of them passionate, well-meaning, and patient-led. While this content can offer valuable insight, it’s important to remember that medical cannabis is highly individualised. What works for one person may not be right for another.

That’s why clinical decisions should always be grounded in evidence and guided by healthcare professionals who understand each patient’s unique needs. Personal stories have power, but they should complement, not replace, medical expertise.

We must strike a balance. Patients gain significant advantages from interacting with people who share their medical experiences. Sharing accurate information must go hand in hand with building trusted pathways that connect patients to qualified clinicians.

Medical cannabis brands who adopt pseudo-recreational approaches under medical legality threaten to create four major problems:

We need to create a credible structure because we have both the chance and duty to do so. The medical cannabis system should provide dependable solutions which doctors endorse and regulatory authorities support. We need to maintain a standard that exceeds basic requirements.

Creative freedom allows us to explore new ideas, but science must always remain at the forefront. In a field where medical understanding of cannabis is still developing, presentation carries weight; it signals credibility. That’s why every message we share should reinforce clarity, accuracy, and alignment with the principles of evidence-based medicine.

Matt Clifton – Chief Communications Officer at Dalgety

Championing trust, clarity, and care in medical cannabis.

Disclaimer: 

The information provided in this blog is for educational purposes only and is intended for healthcare professionals involved in the prescribing and administration of cannabis-based medicinal products (CBMPs). It does not constitute medical advice, diagnosis, or treatment recommendations. While every effort has been made to ensure accuracy, regulatory guidelines and clinical best practices may evolve. Prescribers should refer to the latest guidance from the Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE), and other relevant bodies when making treatment decisions. Dalgety does not endorse any specific product or treatment pathway and encourages healthcare professionals to exercise their clinical judgement in patient care.